The future will likely prioritize hybrid models that integrate pharmacotherapy with structured lifestyle support, but further research is needed to address long-term maintenance, cost, and health equity ( Figure 1 )
Compounding Rules May Change Compounded peptide availability depends on current regulatory requirements, pharmacy policies, ingredient access and individualized prescribing decisions
GLP-1 slows gastric emptying, increases satiety, and triggers insulin release after meals
That distinction matters clinically, especially when women account for roughly 75% of people seeking medical treatment for obesity and excess weight
Long-term clinical outcome in patients with glutathione synthetase deficiency
Published online May 2024